2328070-52-4
2328070-52-4
Chemical Structure
Pomalidomide-amido-PEG3-C2-NH2
Synonym(s): Cereblon Ligand-Linker Conjugates 22; E3 ligase Ligand-Linker Conjugates 55
- CAS No.: 2328070-52-4
- Formula:C22H28N4O8
- Molecular Weight:476.48
IUPAC Name: 3-(2-(2-(2-aminoethoxy)ethoxy)ethoxy)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)propanamide
InChIKey: FEXCPYUYLOFYGF-UHFFFAOYSA-N
SMILES: O=C(NC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O)CCOCCOCCOCCN
Biological Activity: Pomalidomide-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 22) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Pomalidomide-amido-PEG3-C2-NH2 | 99.11% | Pomalidomide-amido-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 22) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-PEG3-C2-NH2 | Pomalidomide-PEG3-C2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-PEG3-C2-NH2 hydrochloride | 96.64% | Pomalidomide-PEG3-C2-NH2 (Cereblon Ligand-Linker Conjugates 5) hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-amino-PEG5-NH2 | Pomalidomide-amino-PEG5-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-amino-PEG3-NH2 hydrochloride | Pomalidomide-amino-PEG3-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-amino-PEG3-NH2 | Pomalidomide-amino-PEG3-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Thalidomide-NH-PEG3-propionic acid | 99.15% | Thalidomide-NH-PEG3-propionic acid is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 3-unit PEG linker used in PROTAC technology. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Thalidomide-amido-PEG2-NH2 | Thalidomide-amido-PEG2-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Thalidomide-amido-PEG2-NH2 hydrochloride | Thalidomide-amido-PEG2-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-amino-PEG4-NH2 | Pomalidomide-amino-PEG4-NH2 is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Pomalidomide-amino-PEG4-NH2 hydrochloride | 99.27% | Pomalidomide-amino-PEG4-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and a linker used in PROTAC technology. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
